IngentaConnect Interferon-alpha (IFN-) stimulates anti-melanoma cytotoxic T lymp...

Authors: Palmer, K. J.¹; Harries, M.¹; Gore, M. E.²; Collins, M. K. L.¹

Source: Clinical & Experimental Immunology, Volume 119, Number 3, March 2000 , pp. 412-418(7)

Abstract:

IFN-α administration after primary tumour resection improves the survival of melanoma patients at high risk of relapse. To investigate whether this response might be due to stimulation of anti-tumour immunity, the effect of IFN-α on anti-melanoma CTL generation in MLTC was measured. IFN-α increased both allogeneic and autologous anti-melanoma CTL generation from peripheral blood lymphocytes stimulated with irradiated primary melanoma cultures. IFN-α up-regulated MHC class I expression on primary melanoma cultures, whereas IFN-γ up-regulated both MHC class I and II expression. However, the effect of IFN-α on anti-melanoma CTL generation was often more potent than that of IFN-γ, equalling the effect of the optimal combination of IL-2 and IL-12. Pre-treatment of primary melanoma cultures with IFN-γ was sufficient for CTL generation in MLTC, whereas IFN-α needed to be present during the MLTC. While direct anti-proliferative effects of IFN-α on some tumour cells have been described, IFN-α did not inhibit proliferation of primary melanoma cultures. These results suggest that the clinical effects of IFN-α in melanoma patients may be immune-mediated.

Keywords: IFN-α; cytotoxic T cell; melanoma

Document Type: Research article

DOI: 10.1046/j.1365-2249.2000.01159.x

Affiliations: 1: Department of Immunology, University College London, Windeyer Institute of Medical Science, and 2: Skin and Melanoma Unit, The Royal Marsden Hospital, London, UK

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Interferon-alpha (IFN-α) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC)